| Dr Ronald Blake Smith, MD | |
|
2610 S Lamar Blvd, Oxford, MS 38655-5243 | |
| (662) 234-1731 | |
| (662) 236-2392 |
| Full Name | Dr Ronald Blake Smith |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 33 Years |
| Location | 2610 S Lamar Blvd, Oxford, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346235850 | NPI | - | NPPES |
| 00119567 | Medicaid | MS | |
| 00125758 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 13212 (Mississippi) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oxford Clinic For Women Pllc | 0042541435 | 5 |
| Southern Women's Health, Pllc | 2567497985 | 38 |
News Archive
Over 40 per cent of Canadians diagnosed with a life-threatening disease, such as diabetes, feel confused or overwhelmed after leaving their doctor's office, shows a Leger Marketing survey commissioned by the Rexall family of pharmacies.
Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, announced today the issuance of one new European patent for the company's AtherOx® (oxLDL/B2GPI) technology and the publication of an important clinical trial studying oxLDL/B2GPI levels in patients with acute coronary syndrome (ACS).
The University of Texas Health Science Center at Houston has begun enrollment for the first Phase I safety study approved by the Food and Drug Administration to investigate the use of a child's own umbilical cord blood stem cells for traumatic brain injury in children.
Scientists have used a new high-speed, in vitro selection method to isolate 9 antibody-like proteins (ALPs) that bind to the SARS-CoV-2 virus - 4 of which also exhibited neutralizing activity - within 4 days, according to a new study.
› Verified 4 days ago
| Entity Name | Southern Women's Health, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174744379 PECOS PAC ID: 2567497985 Enrollment ID: O20051004000733 |
News Archive
Over 40 per cent of Canadians diagnosed with a life-threatening disease, such as diabetes, feel confused or overwhelmed after leaving their doctor's office, shows a Leger Marketing survey commissioned by the Rexall family of pharmacies.
Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, announced today the issuance of one new European patent for the company's AtherOx® (oxLDL/B2GPI) technology and the publication of an important clinical trial studying oxLDL/B2GPI levels in patients with acute coronary syndrome (ACS).
The University of Texas Health Science Center at Houston has begun enrollment for the first Phase I safety study approved by the Food and Drug Administration to investigate the use of a child's own umbilical cord blood stem cells for traumatic brain injury in children.
Scientists have used a new high-speed, in vitro selection method to isolate 9 antibody-like proteins (ALPs) that bind to the SARS-CoV-2 virus - 4 of which also exhibited neutralizing activity - within 4 days, according to a new study.
› Verified 4 days ago
| Entity Name | Oxford Clinic For Women |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508999871 PECOS PAC ID: 6800967324 Enrollment ID: O20080611000217 |
News Archive
Over 40 per cent of Canadians diagnosed with a life-threatening disease, such as diabetes, feel confused or overwhelmed after leaving their doctor's office, shows a Leger Marketing survey commissioned by the Rexall family of pharmacies.
Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, announced today the issuance of one new European patent for the company's AtherOx® (oxLDL/B2GPI) technology and the publication of an important clinical trial studying oxLDL/B2GPI levels in patients with acute coronary syndrome (ACS).
The University of Texas Health Science Center at Houston has begun enrollment for the first Phase I safety study approved by the Food and Drug Administration to investigate the use of a child's own umbilical cord blood stem cells for traumatic brain injury in children.
Scientists have used a new high-speed, in vitro selection method to isolate 9 antibody-like proteins (ALPs) that bind to the SARS-CoV-2 virus - 4 of which also exhibited neutralizing activity - within 4 days, according to a new study.
› Verified 4 days ago
| Entity Name | Obhg Mississippi Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083995674 PECOS PAC ID: 7416120407 Enrollment ID: O20111108000567 |
News Archive
Over 40 per cent of Canadians diagnosed with a life-threatening disease, such as diabetes, feel confused or overwhelmed after leaving their doctor's office, shows a Leger Marketing survey commissioned by the Rexall family of pharmacies.
Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, announced today the issuance of one new European patent for the company's AtherOx® (oxLDL/B2GPI) technology and the publication of an important clinical trial studying oxLDL/B2GPI levels in patients with acute coronary syndrome (ACS).
The University of Texas Health Science Center at Houston has begun enrollment for the first Phase I safety study approved by the Food and Drug Administration to investigate the use of a child's own umbilical cord blood stem cells for traumatic brain injury in children.
Scientists have used a new high-speed, in vitro selection method to isolate 9 antibody-like proteins (ALPs) that bind to the SARS-CoV-2 virus - 4 of which also exhibited neutralizing activity - within 4 days, according to a new study.
› Verified 4 days ago
| Entity Name | Oxford Clinic For Women Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578105540 PECOS PAC ID: 0042541435 Enrollment ID: O20191016002144 |
News Archive
Over 40 per cent of Canadians diagnosed with a life-threatening disease, such as diabetes, feel confused or overwhelmed after leaving their doctor's office, shows a Leger Marketing survey commissioned by the Rexall family of pharmacies.
Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, announced today the issuance of one new European patent for the company's AtherOx® (oxLDL/B2GPI) technology and the publication of an important clinical trial studying oxLDL/B2GPI levels in patients with acute coronary syndrome (ACS).
The University of Texas Health Science Center at Houston has begun enrollment for the first Phase I safety study approved by the Food and Drug Administration to investigate the use of a child's own umbilical cord blood stem cells for traumatic brain injury in children.
Scientists have used a new high-speed, in vitro selection method to isolate 9 antibody-like proteins (ALPs) that bind to the SARS-CoV-2 virus - 4 of which also exhibited neutralizing activity - within 4 days, according to a new study.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ronald Blake Smith, MD 2610 S Lamar Blvd, Oxford, MS 38655-5243 Ph: (662) 234-1731 | Dr Ronald Blake Smith, MD 2610 S Lamar Blvd, Oxford, MS 38655-5243 Ph: (662) 234-1731 |
News Archive
Over 40 per cent of Canadians diagnosed with a life-threatening disease, such as diabetes, feel confused or overwhelmed after leaving their doctor's office, shows a Leger Marketing survey commissioned by the Rexall family of pharmacies.
Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, announced today the issuance of one new European patent for the company's AtherOx® (oxLDL/B2GPI) technology and the publication of an important clinical trial studying oxLDL/B2GPI levels in patients with acute coronary syndrome (ACS).
The University of Texas Health Science Center at Houston has begun enrollment for the first Phase I safety study approved by the Food and Drug Administration to investigate the use of a child's own umbilical cord blood stem cells for traumatic brain injury in children.
Scientists have used a new high-speed, in vitro selection method to isolate 9 antibody-like proteins (ALPs) that bind to the SARS-CoV-2 virus - 4 of which also exhibited neutralizing activity - within 4 days, according to a new study.
› Verified 4 days ago
Dr. Samuel Ward Cole, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2610 South Lamar Blvd, Oxford, MS 38655 Phone: 662-234-1731 Fax: 662-236-2392 | |
Dr. Ira Lamar Couey, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2200 S Lamar Blvd, Oxford, MS 38655 Phone: 662-234-1731 | |
Julie G Harper, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1204 Medical Park Dr, Oxford, MS 38655 Phone: 901-236-5717 Fax: 662-234-4016 | |
Dr. Gregory Orin Patton, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1204 Medical Park Dr, Oxford, MS 38655 Phone: 662-236-5717 Fax: 662-234-4016 | |
Dr. William Elliott Henderson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2610 S Lamar Blvd, Oxford, MS 38655 Phone: 662-234-1731 Fax: 662-236-2392 | |
Dr. Marion Glenn Hunt, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1204 Medical Park Dr, Oxford, MS 38655 Phone: 662-236-5717 Fax: 662-234-4016 |